Search
for
Sort by
Research 571–600 of 876
- FFA and Personal Care Product Use: A Systematic Review and Meta-Analysis
- Peroxisome Proliferator Activated Receptors Gamma Serum levels and Gene Polymorphism in Frontal Fibrosing Alopecia: A Case Control Study
- Chemotoxicity in Carcinoma Breast Patients - Its Incidence and Trends in Severity - An Observational Study
- Retrospektive Analyse von Wirksamkeit, Sicherheit, prognostischen Parametern und Faktoren der Lebensqualität bei der topischen Immuntherapie der Alopecia areata mit Diphenylcyclopropenon
- Answers to CME examination
- Vaccines, Infections, and Alopecia Areata
- Alopecias
- Hair, Cutaneous Homeostasis and Stem Cell Functions
- Table of Contents
- Abstracts Pt.30
- Disorders of hair in children
- A falling out following minoxidil: Telogen effluvium
- HAIR | Overview
- Amla: An ancient medicinal plant with wide-ranging properties
- Postępowanie kosmetologiczne w wybranych jednostkach chorobowych : podręcznik dla studentów kosmetologii oraz kierunków medycznych
- The biodisposition and hypertrichotic effects of bimatoprost in mouse skin
- Demodicosis of Ophthalmic Concern
- Beard Reconstruction Using Hair Grafts in a Free Flap
- 1017 The prostaglandin F2α analog bimatoprost activates secondary hair germ cells to promote hair growth through two distinct signaling pathways
- Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study
- Alopecia Areata
- The prostamide‐related glaucoma therapy, bimatoprost, offers a novel approach for treating scalp alopecias
- Keratin expression by corneal and limbal stem cells during development
- Safety and Efficacy of Ritlecitinib for the Treatment of Patients with Alopecia Areata: A Systematic Review and Meta-Analysis of Controlled Trials
- Baricitinib: A Review in Severe Alopecia Areata
- Clinical Snippets
- Pediatric and Adolescent Alopecia Areata Treated with JAK Inhibitors: Balancing Efficacy and Safety Across Clinical Trials
- Bimatoprost
- Long‐term efficacy and safety of baricitinib in patients with severe alopecia areata: 104‐week results from BRAVE‐AA1 and BRAVE‐AA2
- Clinical effectiveness of finasteride versus hydroxychloroquine in the treatment of frontal fibrosing alopecia: A randomized controlled trial